外泌体对COPD炎症反应机制的调控作用及药物干预研究进展
聂海逸 , 郭旗 , 张欢欢 , 宋章波 , 吴梦媛 , 苗致铭 , 李洋洋 , 刘聘 , 雍文兴 , 张利英
中国临床药理学与治疗学 ›› 2026, Vol. 31 ›› Issue (10) : 1417 -1429.
外泌体对COPD炎症反应机制的调控作用及药物干预研究进展
Regulatory role of exosome in the inflammatory mechanism of COPD and research progress of drug intervention
慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)是全球常见且危害严重的慢性呼吸系统疾病,以持续性不完全可逆的气流受限为特征,炎症反应贯穿疾病全程。中性粒细胞、巨噬细胞等炎症细胞释放多种炎症介质,激活相关信号通路,促进疾病进展。外泌体作为细胞外囊泡的重要组成部分,直径 30~150 nm,可携带生物活性物质参与机体通讯。研究发现,外泌体在 COPD 炎症反应病理进展中发挥关键作用,既可携带核酸、蛋白质等参与炎症反应,又有望成为 COPD 及炎症反应的诊断标志物与潜在治疗靶点。本文系统综述外泌体在 COPD 炎症反应中的作用机制,深入剖析相关炎症信号通路,并总结基于此的药物防治最新研究成果,旨在为 COPD 的临床治疗提供新的理论依据与干预靶点,助力探索更有效的防治策略。
Chronic obstructive pulmonary disease (COPD) is a prevalent and life - threatening chronic respiratory disease worldwide, characterized by persistent and incompletely reversible airflow limitation, with inflammatory responses occurring throughout the entire disease course. Inflammatory cells such as neutrophils and macrophages secrete a variety of inflammatory mediators, which activate relevant signaling pathways and accelerate disease progression. As a crucial component of extracellular vesicles, exosome range in diameter from 30 to 150 nm and can carry bioactive substances to participate in intercellular communication. Studies have demonstrated that exosome play a pivotal role in the pathological progression of inflammatory responses in COPD: they not only transport nucleic acids, proteins, and other molecules to regulate inflammatory reactions but also hold great promise as diagnostic biomarkers and potential therapeutic targets for COPD and its associated inflammatory responses. This review systematically summarizes the mechanisms underlying the role of exosome in COPD - related inflammatory responses, elaborates on the relevant inflammatory signaling pathways in depth, and highlights the latest research advances in drug - based prevention and treatment strategies targeting these mechanisms. The aim is to provide novel theoretical foundations and intervention targets for the clinical management of COPD, thereby facilitating the development of more effective preventive and therapeutic approaches.
| [1] |
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2025 report[M]. Geneva: World Health Organization,2025. |
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
芮玉娟, 段雯慧, 朱彤彤, |
| [18] |
黄宁, 胡长平. 外泌体在肺部疾病中的研究进展[J].中国药理学通报, 2023, 39(11): 2006-2011. |
| [19] |
Zhu Z, Zhang X, Lin X, |
| [20] |
|
| [21] |
刘路, 齐文川, 曾倩, |
| [22] |
|
| [23] |
|
| [24] |
Fan H, Zhao H, Gao L, |
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
杨洋, 李竹英, 田春燕, |
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
Faiza, |
| [58] |
|
| [59] |
杨岩涛, 杨岩, 肖佳妹, |
| [60] |
|
| [61] |
|
| [62] |
谢淑敏, 郭淑杰, 薛丙权, |
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
赵佳琛, 王艺涵, 金艳, |
| [67] |
徐维佳, 陈揭剑, 严丽群, |
| [68] |
|
| [69] |
|
| [70] |
|
| [71] |
|
| [72] |
|
| [73] |
|
| [74] |
|
| [75] |
|
| [76] |
|
| [77] |
|
| [78] |
|
| [79] |
|
| [80] |
|
| [81] |
|
国家自然科学基金(82160868)
敦煌医学开放课题(DHYX24-23)
优秀研究生创新之星项目(2025CXZX-902)
/
| 〈 |
|
〉 |